News

BridgeBio Pharma, Inc. announced that one rapid-fire abstract and two moderated ePosters on the clinical outcomes and quality of life measures provided by acoramidis in variant transthyretin amyloid cardiomyopathy and one moderated ePoster on...

Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies

First patent significantly advances intellectual property for HeartBeam’s credit card-sized ECG device, bolstering both the defensive and offensive moat around the company’s core technology

EnChannel Medical, a breakthrough innovator in cardiac electrophysiology, today announced the successful completion of an oversubscribed Series B financing, raising $82.2M (600M RMB).

Groundbreaking device sets new standard in the management of patients with an elevated risk of sudden cardiac arrest

Catheter Precision, Inc., a US-based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, announced that new clinical data about VIVO is available.

Milestone results formed the basis of HeartBeam’s 12-lead ECG synthesis software application submitted to FDA in January 2025

Huxley Medical unveiled promising investigational data from the company's SANSA monitoring platform at the Heart Rhythm Society meeting.

New data highlights strong wear compliance, meaningful arrhythmia detection, and continuity of care in community-based advanced practice provider-driven model

iRhythm Technologies, Inc. announced results from a large real-world retrospective analysis presented at the Heart Rhythm Society’s annual meeting, HRS2025.